艾德生物
(300685)
| 流通市值：82.09亿 | | | 总市值：82.50亿 |
| 流通股本：3.90亿 | | | 总股本：3.92亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 876,734,780.23 | 828,873,935.82 | 736,841,008.77 | 804,534,209.54 |
| 应收票据及应收账款 | 556,814,017.83 | 542,105,519.22 | 584,567,059.45 | 571,451,622.92 |
| 其中：应收票据 | 20,615,148.54 | 15,856,231.01 | 10,723,097.87 | 10,943,854.28 |
| 应收账款 | 536,198,869.29 | 526,249,288.21 | 573,843,961.58 | 560,507,768.64 |
| 预付款项 | 18,674,289.46 | 12,851,955.47 | 12,502,342.1 | 10,495,771.7 |
| 其他应收款合计 | 2,473,417.5 | 2,348,321.53 | 2,516,015.9 | 2,273,057.28 |
| 存货 | 34,636,347.03 | 34,365,482.01 | 37,320,993.03 | 33,050,195.3 |
| 合同资产 | 1,024,058.17 | 1,192,823.51 | 2,888,146.64 | 2,612,563.78 |
| 一年内到期的非流动资产 | 5,457,706.54 | 5,322,425.92 | 11,062,145.3 | 10,930,954.32 |
| 其他流动资产 | 12,907,401.49 | 9,453,688.74 | 6,312,142.46 | 4,502,022.44 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,891,421,886.64 | 1,788,399,896.77 | 1,743,106,265.64 | 1,691,758,828.49 |
| 非流动资产: | | | | |
| 长期应收款 | 12,263,822.58 | 12,122,116.14 | 23,730,409.7 | 23,498,516.18 |
| 长期股权投资 | 10,497,291.81 | 11,951,810.18 | 20,574,590.68 | 22,367,555.96 |
| 固定资产 | 170,749,929.32 | 173,256,020.58 | 182,566,429.72 | 182,924,744 |
| 使用权资产 | 11,837,434.89 | 12,997,943.06 | 5,622,163.48 | 6,398,539.93 |
| 无形资产 | 45,285,167.34 | 43,582,741.36 | 45,347,653.38 | 47,113,553.98 |
| 长期待摊费用 | 3,524,161.46 | 4,736,367.84 | 4,429,784.24 | 5,019,306.26 |
| 递延所得税资产 | 11,064,822.26 | 10,060,623.33 | 8,417,345.15 | 6,784,678.48 |
| 其他非流动资产 | 6,868,313 | 7,694,191.8 | 1,800,378.6 | 2,342,303.6 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 272,090,942.66 | 276,401,814.29 | 292,488,754.95 | 296,449,198.39 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,163,512,829.3 | 2,064,801,711.06 | 2,035,595,020.59 | 1,988,208,026.88 |
| 流动负债: | | | | |
| 短期借款 | - | - | 5,004,794.52 | 5,004,794.52 |
| 应付票据及应付账款 | 23,171,478.76 | 19,702,291.87 | 21,170,445.3 | 17,655,989.63 |
| 应付账款 | 23,171,478.76 | 19,702,291.87 | 21,170,445.3 | 17,655,989.63 |
| 预收款项 | - | 84,640 | 191,322.67 | 14,120 |
| 合同负债 | 3,669,048.13 | 4,281,980.76 | 5,647,775.41 | 4,102,176.19 |
| 应付职工薪酬 | 46,308,003.48 | 39,558,744.29 | 53,884,728.9 | 41,769,892.66 |
| 应交税费 | 42,724,154.59 | 25,332,940.67 | 18,377,317.04 | 16,826,358.51 |
| 其他应付款合计 | 54,358,251.52 | 57,290,286.04 | 64,032,500.57 | 77,980,232.18 |
| 应付股利 | - | - | - | 11,839,718.16 |
| 一年内到期的非流动负债 | 48,790,761.52 | 48,523,955.23 | 47,944,176.61 | 48,569,636.21 |
| 其他流动负债 | 178,849.05 | 47,739.86 | 65,903.68 | 37,617 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 219,200,547.05 | 194,822,578.72 | 216,318,964.7 | 211,960,816.9 |
| 非流动负债: | | | | |
| 租赁负债 | 7,837,091.1 | 8,732,314.17 | 2,737,297.34 | 3,746,705.25 |
| 递延收益 | 17,628,217.61 | 17,982,060.31 | 8,077,960.01 | 8,847,688.83 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 25,465,308.71 | 26,714,374.48 | 10,815,257.35 | 12,594,394.08 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 244,665,855.76 | 221,536,953.2 | 227,134,222.05 | 224,555,210.98 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 393,061,969 | 398,436,809 | 398,540,309 | 398,540,309 |
| 资本公积 | 136,956,196.36 | 232,079,474.86 | 240,852,345.62 | 234,475,473.56 |
| 减:库存股 | 34,380,996.78 | 120,438,010.16 | 136,777,148.97 | 91,179,033.86 |
| 其他综合收益 | 2,045,483.62 | 2,142,884.84 | 2,404,126.02 | 1,794,121.82 |
| 盈余公积 | 149,842,444.59 | 149,842,444.59 | 128,577,301.26 | 128,577,301.26 |
| 未分配利润 | 1,271,321,876.75 | 1,181,201,154.73 | 1,174,863,865.61 | 1,091,444,644.12 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,918,846,973.54 | 1,843,264,757.86 | 1,808,460,798.54 | 1,763,652,815.9 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,918,846,973.54 | 1,843,264,757.86 | 1,808,460,798.54 | 1,763,652,815.9 |
| 负债和股东权益合计 | 2,163,512,829.3 | 2,064,801,711.06 | 2,035,595,020.59 | 1,988,208,026.88 |
| 公告日期 | 2025-04-22 | 2025-04-22 | 2024-10-22 | 2024-07-30 |
| 审计意见(境内) | | 标准无保留意见 | | |